MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...
The new study, lauded as “a leap beyond previous studies," found that severe infections can lead to long-term cognitive problems. In other news about the brain, the military has begun testing new ways ...